2004 -2017 Director of Bioservices, BB50 Manufacturing @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
Christopher Klem Education
Aspen University
Master of Business Administration - MBA (Pharmaceutical Management)
2016-2021
Rutgers University
B.A. (Economics)
1987-1992
Christopher Klem Skills
Technology Transfer
cGMP
Biopharmaceuticals
GMP
Validation
FDA
Leadership
Biotechnology
Microsoft Office
Customer Service
Strategy
Christopher Klem Summary
Christopher Klem, based in Frenchtown, NJ, US, is currently a Vice President, Commercial Manufacturing at enGene. Christopher Klem brings experience from previous roles at Asklepios BioPharmaceutical, Inc. (AskBio), Spark Therapeutics, Inc. and ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company. Christopher Klem holds a 2016 - 2021 Master of Business Administration - MBA in Pharmaceutical Management @ Aspen University. With a robust skill set that includes Technology Transfer, cGMP, Biopharmaceuticals, GMP, Validation and more. Christopher Klem has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Christopher Klem?
Find contact details for 700 million professionals.